Search > Smoking
My employer runs this trial

Smoking Cessation Medications + Rewards for HIV

Not yet recruiting at 4 trial locations
EJ
JW
Overseen ByJune-Marie Weiss, MA, MEd
Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: Yale University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

Cigarette smoking is an important cause of illness and death among persons with HIV (PWH). This project will study the impact of adding contingency management (use of financial rewards) to receiving medications and counseling on promoting smoking abstinence and other health outcomes among PWH. As treatments will be provided by clinical pharmacists and other team members in HIV clinics, factors relevant for implementing this model to inform real-world practice will also be evaluated.

Who Is on the Research Team?

EJ

E. Jennifer Edelman, MD, MHS

Principal Investigator

Yale University

Are You a Good Fit for This Trial?

This trial is for people living with HIV who smoke cigarettes and want to quit. Participants must be willing to use stop-smoking medications and attend counseling sessions at their HIV clinic.

Inclusion Criteria

I am over 18 years old.
Smoke everyday or some days
Receive care at one of the participating sites
See 4 more

Exclusion Criteria

Inability to read or understand English or Spanish
Exclusive use of non-cigarette tobacco or nicotine products, including e-cigarettes
Self-report or urine testing confirming pregnancy, nursing, or trying to conceive
See 3 more

What Are the Treatments Tested in This Trial?

Interventions

  • Bupropion
  • Multi-target Contingency Management
  • Nicotine Gum
  • Nicotine Lozenge
  • Nicotine Patch
  • Teamlet booster
  • Varenicline

Trial Overview

The study compares standard smoking cessation treatments (nicotine patch, gum, lozenge, varenicline, bupropion) plus counseling versus the same treatments combined with financial rewards for quitting. Care is provided by a team in HIV clinics.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: Clinical pharmacist-prescribed MTUD with teamlet boosterExperimental Treatment2 Interventions
Group II: Clinical pharmacist-prescribed MTUD + teamlet delivered CM and boosterExperimental Treatment3 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials
1,963
Recruited
3,046,000+

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Collaborator

Trials
865
Recruited
1,091,000+

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.